Results 171 to 180 of about 63,859 (253)

Gut Microbiota Dysbiosis and Gut-Nasal Axis Alterations in Preschool Children with Allergic Rhinitis and Functional Constipation. [PDF]

J Asthma Allergy
Yang W, Li X, Wang C, Li X, Huang C.
europepmc   +1 more source

Functional constipation in pediatric patients: an observational study in southern Brazil. [PDF]

Sao Paulo Med J
Cardoso ADS, Oliveira LB, Sonego M.
europepmc   +1 more source

Patient outcomes in KCNQ2 developmental and epileptic encephalopathy

Developmental Medicine &Child Neurology, EarlyView.
Abstract The aim of this study was to review and summarize the literature describing clinically observed or caregiver‐reported and patient‐reported KCNQ2 developmental and epileptic encephalopathy (DEE) outcomes. Three online databases and selected congress proceedings were searched (August 2023).
Grant Maclaine, Michele H. Potashman, Deepshikha Pawar, Sugandh Sharma, Katja Rudell, Jason Lerner, Vlad Coric, Anne T. Berg, John Millichap, Gil L'Italien   +9 more
wiley   +1 more source

Current Treatment Options for Children with Functional Constipation-What Is in the Pipeline? [PDF]

Children (Basel)
Jonker CAL, van Os TM, Gorter RR, Levitt MA, Benninga MA.   +4 more
europepmc   +1 more source

Pain trajectories in children and adolescents with cerebral palsy: A longitudinal population‐based register study

Developmental Medicine &Child Neurology, EarlyView.
Four pain trajectories were identified in a population‐based register study of 4887 children and adolescents with cerebral palsy: (1) increasing trend, low probability of experiencing pain (20.28%), (2) increasing trend, high probability of experiencing pain (30.30%), (3) decreasing trend (26.85%), and (4) consistently high probability of experiencing ...
May Phyu Sin, Johan Jarl, David L. Roth, Ann I. Alriksson‐Schmidt   +3 more
wiley   +1 more source

Association Between Functional Constipation and Growth Status in Children Based on Anthropometric Indices. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Oswari H, Junaidi MC, Oswari JS, Suriadi R, Lazarus G, Kadim M.   +5 more
europepmc   +1 more source

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To provide a comprehensive overview of the cardiovascular and renal effects of glucose‐dependent insulinotropic polypeptide (GIP) by integrating its physiological role with recent human trial data on tirzepatide, the first dual GIP and glucagon‐like peptide‐1 (GLP‐1) receptor agonist.
Michelantonio De Fano, Line L. Haurum, Christine R. Schwarz, Francesca Porcellati, Andreas Andersen   +4 more
wiley   +1 more source

Efficacy and safety of non-pharmacological treatments for paediatric functional constipation: a systematic review and meta-analysis. [PDF]

BMJ Paediatr Open
Arruda Navarro Albuquerque D, de Geus A, Gordon M, Sinopoulou V, Khan MS, Ajiboye A, Liu S, Benninga MA, Tabbers M.   +8 more
europepmc   +1 more source

Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Tirzepatide is a once‐weekly glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist (RA) approved for weight management in adults with obesity. Data on older adults remain limited, however. This study aimed to examine tirzepatide's safety and efficacy in adults aged ≥ 65 years with obesity ...
Nasreen Alfaris, Robert F. Kushner, Jianghao Li, Kevin L. Chen, Mia Fenimore, Boris Calderon, Adam Stefanski   +6 more
wiley   +1 more source